CAPTOPRIL - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for captopril and what is the scope of patent protection?

Captopril is the generic ingredient in seven branded drugs marketed by Strides Pharma, Ajanta Pharma Ltd, Andas 5 Holding, Apothecon, Aurobindo Pharma Usa, Changzhou Pharm, Chartwell Rx, Corepharma, Cosette, Dava Pharms Inc, Egis Pharms, G And W Labs Inc, Hikma Intl Pharms, Oxford Pharms, Prinston Inc, Purepac Pharm, Sandoz, Seton Pharms, Teva, Watson Labs, Wockhardt, Ivax Sub Teva Pharms, and Rising, and is included in thirty-three NDAs. Additional information is available in the individual branded drug profile pages.

There are fifteen drug master file entries for captopril. Thirteen suppliers are listed for this compound.

Summary for CAPTOPRIL

US Patents:	0
Tradenames:	7
Applicants:	23
NDAs:	33
Drug Master File Entries:	15
Finished Product Suppliers / Packagers:	13
Raw Ingredient (Bulk) Api Vendors:	118
Clinical Trials:	50
Patent Applications:	6,348
Drug Prices:	Drug price trends for CAPTOPRIL
What excipients (inactive ingredients) are in CAPTOPRIL?	CAPTOPRIL excipients list
DailyMed Link:	CAPTOPRIL at DailyMed

See drug prices for CAPTOPRIL

Recent Clinical Trials for CAPTOPRIL

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Natural Wellness Egypt	Phase 3
Shanghai Jiao Tong University School of Medicine	Phase 4
Iain Bressendorff	Phase 2

See all CAPTOPRIL clinical trials

Pharmacology for CAPTOPRIL

Drug Class	Angiotensin Converting Enzyme Inhibitor
Mechanism of Action	Angiotensin-converting Enzyme Inhibitors

Medical Subject Heading (MeSH) Categories for CAPTOPRIL

Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Agents

Anatomical Therapeutic Chemical (ATC) Classes for CAPTOPRIL

C09AA	ACE inhibitors, plain
C09A	ACE INHIBITORS, PLAIN
C09	AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
C	Cardiovascular system

US Patents and Regulatory Information for CAPTOPRIL

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Watson Labs	CAPTOPRIL	captopril	TABLET;ORAL	074576-003	Apr 23, 1996		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Ivax Sub Teva Pharms	CAPTOPRIL AND HYDROCHLOROTHIAZIDE	captopril; hydrochlorothiazide	TABLET;ORAL	075055-004	Jun 18, 1998		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Cosette	CAPTOPRIL AND HYDROCHLOROTHIAZIDE	captopril; hydrochlorothiazide	TABLET;ORAL	074827-004	Dec 29, 1997		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Apothecon	CAPOZIDE 25/15	captopril; hydrochlorothiazide	TABLET;ORAL	018709-001	Oct 12, 1984		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for CAPTOPRIL

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Strides Pharma	CAPOTEN	captopril	TABLET;ORAL	018343-004	Jun 13, 1995	⤷ Sign Up	⤷ Sign Up
Strides Pharma	CAPOTEN	captopril	TABLET;ORAL	018343-003	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Strides Pharma	CAPOTEN	captopril	TABLET;ORAL	018343-003	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Strides Pharma	CAPOTEN	captopril	TABLET;ORAL	018343-005	Jan 17, 1985	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.